Dating Violence Victimization, Nonmedical Rx Med Use Linked

This article originally appeared here.
Share this content:
Dating Violence Victimization, Nonmedical Rx Med Use Linked
Dating Violence Victimization, Nonmedical Rx Med Use Linked

MONDAY, Nov. 20, 2017 (HealthDay News) -- For male and female high school students, nonmedical use of prescription drugs (NMUPD) is associated with experiences of dating violence victimization (DVV), according to a study published online Nov. 20 in Pediatrics.

Heather B. Clayton, Ph.D., M.P.H., from the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues used data from the 2015 national Youth Risk Behavior Survey for students in grades 9 to 12 to examine the correlation between lifetime NMUPD and DVV. Data were included for 5,136 boys and 5,307 girls who dated during the 12 months before the survey.

The researchers found that compared with female students, male students had a significantly lower prevalence of DVV. After adjustment for covariates, sexual DVV only and both physical and sexual DVV were positively correlated with NMUPD among boys (adjusted prevalence ratios, 1.61 and 1.65, respectively). For girls, positive correlations with NMUPD were seen for physical DVV only and both physical and sexual DVV (adjusted prevalence ratios, 1.42 and 1.43, respectively).

"Community- or school-based adolescent violence and substance use prevention efforts would be enhanced by considering the association between DVV and substance use, particularly NMUPD among both male and female adolescents, to address these public health problems," the authors write.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

ASH: Anti-CD19 CAR T-Cell Tx Beneficial in B-Cell Lymphomas

ASH: Anti-CD19 CAR T-Cell Tx Beneficial in B-Cell ...

Second study shows benefit in relapsed or refractory B-cell lymphoma, follicular lymphoma

ASH: AAVD Beats ABVD for Advanced Hodgkin's Lymphoma

ASH: A+AVD Beats ABVD for Advanced Hodgkin's Lymphoma

Lower combined risk of progression, death, or noncomplete response with A+AVD

ASH: High-Dose Gene Transfer Beneficial in Severe Hemophilia A

ASH: High-Dose Gene Transfer Beneficial in Severe Hemophilia ...

Factor VIII gene transfer tied to sustained normalization of factor VIII activity levels

is free, fast, and customized just for you!

Already a member?

Sign In Now »